Medicare:

Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy

PEMD-92-28: Published: Jul 17, 1992. Publicly Released: Aug 17, 1992.

Additional Materials:

Contact:

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

Pursuant to a congressional request, GAO examined factors that influence where oncologists treat Medicare patients and the potential cost to the federal government of treatment in different settings.

GAO found that: (1) some oncologists have treated cancer patients in hospital inpatient and outpatient settings when, by clinical standards, these patients could have received treatment in the office; (2) oncologists interviewed consistently stated that their choice of treatment setting was influenced by whether they expected reimbursement to be adequate if they provided treatment in the office setting; and (3) treatment in the hospital inpatient setting was more expensive to Medicare than hospital outpatient or office treatment settings.

Nov 15, 2017

Nov 14, 2017

Nov 13, 2017

Nov 6, 2017

Oct 31, 2017

Oct 18, 2017

Oct 4, 2017

Looking for more? Browse all our products here